Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic ...
FDA approved Optune Pax with gemcitabine/nab-paclitaxel, applying alternating electric fields to disrupt mitosis via abdominal arrays, expanding noninvasive, home ...
The U.S. Food and Drug Administration has approved a first-of-its-kind, noninvasive device, the Optune Pax, for the treatment of adult patients with locally advanced pancreatic cancer. Approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results